![Eric Daniels](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Daniels
Corporate Officer/Principal chez
PLUS THERAPEUTICS, INC.
Fortune : 88 193 $ au 31/05/2026
Profil
Eric J.
Daniels is the founder of Okogen, Inc., Bayon Therapeutics, Inc. Dr. Daniels is currently Chief Development Officer at Plus Therapeutics, Inc. since 2026.
Formerly, Dr. Daniels was Chief Development Officer at Kiora Pharmaceuticals, Inc. from 2021 to 2026 and Chief Executive Officer at OccuRx Pty Ltd. Education includes undergraduate studies at the University of California, Berkeley, a doctorate from David Geffen School of Medicine, and an MBA from Anderson School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/04/2026 | 32 908 ( 0,74 % ) | 88 193 $ | 31/05/2026 |
Postes actifs de Eric Daniels
| Sociétés | Poste | Début |
|---|---|---|
| PLUS THERAPEUTICS, INC. | Corporate Officer/Principal | 20/04/2026 |
Okogen, Inc.
 Okogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as an ophthalmic pharmaceutical company | Fondateur | - |
Bayon Therapeutics, Inc. | Fondateur | - |
Anciens postes connus de Eric Daniels
| Sociétés | Poste | Fin |
|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 17/04/2026 |
OccuRx Pty Ltd
 OccuRx Pty Ltd Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Directeur Général | - |
Formation de Eric Daniels
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Kiora Pharmaceuticals, Inc.
 Kiora Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Plus Therapeutics, Inc.
 Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
David Geffen School of Medicine
 David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anderson School of Management
 Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OccuRx Pty Ltd
OccuRx Pty Ltd Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Health Technology |
Okogen, Inc.
Okogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as an ophthalmic pharmaceutical company | Health Technology |
Bayon Therapeutics, Inc. |
